(Q39637660)

English

Cisplatin and a potent platinum(IV) complex-mediated enhancement of TRAIL-induced cancer cells killing is associated with modulation of upstream events in the extrinsic apoptotic pathway.

scientific article published on 29 October 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21037225%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Cisplatin and a potent platinum(IV) complex-mediated enhancement of TRAIL-induced cancer cells killing is associated with modulation of upstream events in the extrinsic apoptotic pathway (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21037225%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

apoptotic process

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Olga Vondálová Blanárová

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21037225%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

13

object named as

Alois Kozubík

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21037225%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

author name string

Iva Jelínková

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21037225%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Arpád Szöor

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21037225%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Belma Skender

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21037225%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Karel Soucek

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21037225%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Viktor Horváth

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21037225%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Alena Vaculová

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21037225%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Ladislav Andera

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21037225%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Petr Sova

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21037225%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

János Szöllosi

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21037225%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Jirina Hofmanová

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21037225%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

György Vereb

12

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21037225%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

language of work or name

0 references

publication date

29 October 2010

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21037225%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21037225%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

32

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21037225%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

42-51

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21037225%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21037225%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Tumor therapeutics by design: targeting and activation of death receptors

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ220

21 January 2018

Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo.

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ220

21 January 2018

The promise of TRAIL--potential and risks of a novel anticancer therapy

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ220

21 January 2018

Zinc chelation induces rapid depletion of the X-linked inhibitor of apoptosis and sensitizes prostate cancer cells to TRAIL-mediated apoptosis

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ220

21 January 2018

A mitochondrial block and expression of XIAP lead to resistance to TRAIL-induced apoptosis during progression to metastasis of a colon carcinoma

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ220

21 January 2018

Receptor-selective mutants of apoptosis-inducing ligand 2/tumor necrosis factor-related apoptosis-inducing ligand reveal a greater contribution of death receptor (DR) 5 than DR4 to apoptosis signaling

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ220

21 January 2018

Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ220

21 January 2018

Differential modulation of apoptosis sensitivity in CD95 type I and type II cells.

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ220

21 January 2018

Relief of extrinsic pathway inhibition by the Bid-dependent mitochondrial release of Smac in Fas-mediated hepatocyte apoptosis

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ220

21 January 2018

Cholesterol-dependent clustering of IL-2Ralpha and its colocalization with HLA and CD48 on T lymphoma cells suggest their functional association with lipid rafts.

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ220

21 January 2018

Dynamic, yet structured: The cell membrane three decades after the Singer-Nicolson model

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ220

21 January 2018

Lipid rafts and nonrafts mediate tumor necrosis factor related apoptosis-inducing ligand induced apoptotic and nonapoptotic signals in non small cell lung carcinoma cells.

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ220

21 January 2018

CD95 death-inducing signaling complex formation and internalization occur in lipid rafts of type I and type II cells.

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ220

21 January 2018

The role of receptor internalization in CD95 signaling

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ220

21 January 2018

Receptor-mediated endocytosis is not required for tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis.

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ220

21 January 2018

Cisplatin-dependent upregulation of death receptors 4 and 5 augments induction of apoptosis by TNF-related apoptosis-inducing ligand against esophageal squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ220

21 January 2018

Chemotherapeutic agents sensitize osteogenic sarcoma cells, but not normal human bone cells, to Apo2L/TRAIL-induced apoptosis.

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ220

21 January 2018

Quercetin enhances TRAIL-mediated apoptosis in colon cancer cells by inducing the accumulation of death receptors in lipid rafts.

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ220

21 January 2018

Oxaliplatin enhances TRAIL-induced apoptosis in gastric cancer cells by CBL-regulated death receptor redistribution in lipid rafts

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ220

21 January 2018

Akt promotes chemoresistance in human ovarian cancer cells by modulating cisplatin-induced, p53-dependent ubiquitination of FLICE-like inhibitory protein

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ220

21 January 2018

Sp1-like sequences mediate human caspase-3 promoter activation by p73 and cisplatin

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ220

21 January 2018

Enhancement of Apo2L/TRAIL-mediated cytotoxicity in esophageal cancer cells by cisplatin

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ220

21 January 2018

New platinum(IV) complex with adamantylamine ligand as a promising anti-cancer drug: comparison of in vitro cytotoxic potential towards A2780/cisR cisplatin-resistant cell line within homologous series of platinum(IV) complexes

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ220

21 January 2018

High effectiveness of platinum(IV) complex with adamantylamine in overcoming resistance to cisplatin and suppressing proliferation of ovarian cancer cells in vitro.

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ220

21 January 2018

Platinum(IV) complex with adamantylamine overcomes intrinsic resistance to cisplatin in ovarian cancer cells.

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ220

21 January 2018

Different cell cycle modulation following treatment of human ovarian carcinoma cells with a new platinum(IV) complex vs cisplatin.

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ220

21 January 2018

The novel platinum(IV) complex LA-12 induces p53 and p53/47 responses that differ from the related drug, cisplatin

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ220

21 January 2018

The new platinum(IV) derivative LA-12 shows stronger inhibitory effect on Hsp90 function compared to cisplatin.

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ220

21 January 2018

Preclinical anti-tumor activity of a new oral platinum(IV) drug LA-12.

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ220

21 January 2018

Comparative anti-tumor efficacy of two orally administered platinum(IV) drugs in nude mice bearing human tumor xenografts

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ220

21 January 2018

Wnt-expressing rat embryonic fibroblasts suppress Apo2L/TRAIL-induced apoptosis of human leukemia cells.

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ220

21 January 2018

Dynamic and label-free cell-based assays using the real-time cell electronic sensing system

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ220

21 January 2018

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ220

21 January 2018

Human fetal colon cells and colon cancer cells respond differently to butyrate and PUFAs

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ220

21 January 2018

TRAIL and other TRAIL receptor agonists as novel cancer therapeutics

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ220

21 January 2018

Preclinical differentiation between apparently safe and potentially hepatotoxic applications of TRAIL either alone or in combination with chemotherapeutic drugs.

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ220

21 January 2018

TRAIL/bortezomib cotreatment is potentially hepatotoxic but induces cancer-specific apoptosis within a therapeutic window.

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ220

21 January 2018

Chemotherapeutic agents enhance TRAIL-induced apoptosis in prostate cancer cells

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ220

21 January 2018

Prospective antitumor effects of the combination of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and cisplatin against esophageal squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ220

21 January 2018

Anti-tumor activity of the TRA-8 anti-DR5 antibody in combination with cisplatin in an ex vivo human cervical cancer model

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ220

21 January 2018

Cisplatin inactivation of caspases inhibits death ligand-induced cell death in vitro and fulminant liver damage in mice.

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ220

21 January 2018

TRAIL-induced cell death and caspase-8 activation are inhibited by cisplatin but not carboplatin

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ220

21 January 2018

Chemotherapeutic agents sensitize sarcoma cell lines to tumor necrosis factor-related apoptosis-inducing ligand-induced caspase-8 activation, apoptosis and loss of mitochondrial membrane potential

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ220

21 January 2018

Proteasome inhibitors enhance TRAIL-induced apoptosis through the intronic regulation of DR5: involvement of NF-kappa B and reactive oxygen species-mediated p53 activation

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ220

21 January 2018

Cisplatin-induced CD95 redistribution into membrane lipid rafts of HT29 human colon cancer cells.

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ220

21 January 2018

Depsipeptide (FR901228) enhances the cytotoxic activity of TRAIL by redistributing TRAIL receptor to membrane lipid rafts

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ220

21 January 2018

Tumor necrosis factor-related apoptosis-inducing ligand activates a lysosomal pathway of apoptosis that is regulated by Bcl-2 proteins

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ220

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39637660&oldid=1829386339"